For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Pharmacokinetics is the mathematics of the time course of absorption, distribution, metabolism, and excretion of drugs in the body. In an effort to examine the effectiveness of Anti-PEG RabMAb primary antibodies to track the metabolism rate of a PEGylated antigen within an animal model, the following experiment was performed.
1. A rat was injected intraperitineally using 100ug of
mouse IgG-PEG as an antigen.
2. Blood was drawn at 0.5, 1, 2, 4, 10, 24 and 48 hours post-injection.
3. The antiserum was extracted and tested for IgG concentrations
using Anti-PEG RabMAb primary antibody in an ELISA assay.
4. In a 96-well plate coated with 5ug/mL of Anti-PEG RabMAb primary
antibody (ab51257, clone: PEG-B-47), PEG-HRP and the antiserum
5. Using quantified IgG concentrations from the rat antiserum along with
a standard curve generated from an IgG-PEG + HRP-PEG competitive
assay (Fig. 1), the concentration of injected mouse IgG-PEG over time
can be determined (Fig. 2).
As demonstrated below, Anti-PEG RabMAb primary antibodies can be a used to accurately quantify targets of interest and investigate the pharmacokinetcs of PEGylated drugs or antigens within a system (Fig. 2).
Try one of our anti-PEG rabbit monoclonal antibodies by requesting a free sample today. For more information click here.
Fig 1. Mouse IgG-PEG and PEG-HRP competitive ELISA assay using
varying amounts of IgG-PEG and PEG-HRP at a dilution factor of